Skip to main content

MoneyWorks4Me

Piramal Pharma informs about conference call with investor

18 Oct 2023 Evaluate

Pursuant to Regulation 30(6) of the Listing Regulations, Piramal Pharma has informed that it enclosed the details of the Conference Call with investors/ analysts.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..